← Back to Search

Hydration Beverages for Dehydration

N/A

Recruiting

Led By Richard Bloomer, PhD

Research Sponsored by University of Memphis

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Achieve a peak maximal oxygen consumption at screening that is at least 60% of their age and gender matched normative value per American College of Sports Medicine recommendations

Have not had in the 3 months prior to screening or planning to have a major surgery during study period

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at screening

Awards & highlights

Study Summary

This trial tests electrolyte products to replace lost minerals and vitamins from exercise in the heat. Subjects drink one of 3 drinks 30 minutes after exercise and report to the lab 3 times.

Who is the study for?

Adults who regularly exercise, can complete a 90-minute cycling session in heat, and drink at least 2.0 L (women) or 2.5 L (men) of fluid the day before testing. They must not have major surgeries planned, be hypertensive, or have unstable medical conditions that could affect hydration levels.Check my eligibility

What is being tested?

The trial is examining how effective two novel powdered hydration formulas are compared to water for rehydration after moderate-intensity cycling in a hot environment. Participants will try each drink on separate occasions post-exercise to see which one hydrates better.See study design

What are the potential side effects?

Since the products being tested are essentially enhanced hydration beverages with vitamins and electrolytes, side effects may include potential reactions to ingredients if sensitive but generally should be minimal compared to plain water.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My exercise capacity is at least 60% of the expected level for my age and gender.

Select...

I haven't had major surgery in the last 3 months and don't plan to during the study.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at screening

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at screening

This trial's timeline: 3 weeks for screening, Varies for treatment, and at screening for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Body weight

Electrolyte levels

Percent plasma volume

+4 more

Secondary outcome measures

Body temperature

Heart Rate

Heart rate

+7 more

Trial Design

6Treatment groups

Experimental Treatment

Group I: Water, Sugar-Free, Hydration MultiplierExperimental Treatment3 Interventions

Subjects will undergo three 90-min cycling bouts at 70-80% maximal hear rate, 86-89 degrees Fahrenheit, and approximately 50% relative humidity spaced 1-2 weeks apart. Subjects will be provided with a different test drink after each cycling bout at an amount equivalent to150% of sweat losses and evaluated for rehydration. Subjects randomly assigned to this arm will be provided with the experimental/placebo conditions in the following order: water, Liquid IV Sugar-Free Hydration Multiplier, and Liquid IV Hydration Multiplier.

Group II: Water, Hydration Multiplier, Sugar-FreeExperimental Treatment3 Interventions

Subjects will undergo three 90-min cycling bouts at 70-80% maximal hear rate, 86-89 degrees Fahrenheit, and approximately 50% relative humidity spaced 1-2 weeks apart. Subjects will be provided with a different test drink after each cycling bout at an amount equivalent to150% of sweat losses and evaluated for rehydration. Subjects randomly assigned to this arm will be provided with the experimental/placebo conditions in the following order: water, Liquid IV Hydration Multiplier, and Liquid IV Sugar-Free Hydration Multiplier.

Group III: Sugar-Free, Water, Hydration MultiplierExperimental Treatment3 Interventions

Subjects will undergo three 90-min cycling bouts at 70-80% maximal hear rate, 86-89 degrees Fahrenheit, and approximately 50% relative humidity spaced 1-2 weeks apart. Subjects will be provided with a different test drink after each cycling bout at an amount equivalent to150% of sweat losses and evaluated for rehydration. Subjects randomly assigned to this arm will be provided with the experimental/placebo conditions in the following order: Liquid IV Sugar-Free Hydration Multiplier, water, and Liquid IV Hydration Multiplier.

Group IV: Sugar-Free, Hydration Multiplier, WaterExperimental Treatment3 Interventions

Subjects will undergo three 90-min cycling bouts at 70-80% maximal hear rate, 86-89 degrees Fahrenheit, and approximately 50% relative humidity spaced 1-2 weeks apart. Subjects will be provided with a different test drink after each cycling bout at an amount equivalent to150% of sweat losses and evaluated for rehydration. Subjects randomly assigned to this arm will be provided with the experimental/placebo conditions in the following order: Liquid IV Sugar-Free Hydration Multiplier, Liquid IV Hydration Multiplier, and water.

Group V: Hydration Multiplier, Water, Sugar-FreeExperimental Treatment3 Interventions

Subjects will undergo three 90-min cycling bouts at 70-80% maximal hear rate, 86-89 degrees Fahrenheit, and approximately 50% relative humidity spaced 1-2 weeks apart. Subjects will be provided with a different test drink after each cycling bout at an amount equivalent to150% of sweat losses and evaluated for rehydration. Subjects randomly assigned to this arm will be provided with the experimental/placebo conditions in the following order: Liquid IV Hydration Multiplier, water, and Liquid IV Sugar-Free Hydration Multiplier.

Group VI: Hydration Multiplier, Sugar-Free, WaterExperimental Treatment3 Interventions

Subjects will undergo three 90-min cycling bouts at 70-80% maximal hear rate, 86-89 degrees Fahrenheit, and approximately 50% relative humidity spaced 1-2 weeks apart. Subjects will be provided with a different test drink after each cycling bout at an amount equivalent to150% of sweat losses and evaluated for rehydration. Subjects randomly assigned to this arm will be provided with the experimental/placebo conditions in the following order: Liquid IV Hydration Multiplier, Liquid IV Sugar-Free Hydration Multiplier, and water.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Control: Water

2017

N/A

~70

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of MemphisLead Sponsor

70 Previous Clinical Trials

11,864 Total Patients Enrolled

1 Trials studying Dehydration

16 Patients Enrolled for Dehydration

Richard Bloomer, PhDPrincipal InvestigatorUniversity of Memphis

16 Previous Clinical Trials

464 Total Patients Enrolled

1 Trials studying Dehydration

16 Patients Enrolled for Dehydration

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is geriatric participation invited in this experiment?

"As detailed in the requirements for inclusion, applicants must be aged 18 or over and capped at 49 years old."

Answered by AI

Do I meet the criteria to join this experiment?

"Participants aged between 18 and 49 who are experiencing dehydration may qualify for this study, of which the recruitment goal is 25 patients."

Answered by AI

Is there availability for new participants in this medical trial?

"According to the data available on clinicaltrials.gov, this research initiative is currently looking for participants. This medical trial was first posted in September 7th 2023 and its details were last modified on September 29th of the same year."

Answered by AI

How many participants have been gathered for the clinical trial thus far?

"That is correct. According to information available on clinicaltrials.gov, this medical study was posted in September of 2023 and it has been actively seeking candidates since then. Currently, the team is recruiting 25 patients from 1 site."

Answered by AI

What beneficial results is this clinical trial aiming to produce?

"The primary objective of this trial, to be assessed over a 4 hour and 30 minutes window after rehydrating participants, is to measure Plasma Osmolality. Secondary outcomes include Heart Rate monitored during cycling, an assessment of the Rate of Perceived Exertion utilizing a Borg Scale from 6 (easy) to 20 (maximal effort), as well as maximal oxygen consumption determined via a cycling test."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Effects of Two Novel Hydration Beverage Formulas on Rehydration in Adults

Richard Bloomer 2023. "Effects of Two Novel Hydration Beverage Formulas on Rehydration in Adults". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06063655.

All > Dehydration